儿童结核性脑膜炎脑损伤与炎症生物标志物研究
该研究分析了44例结核性脑膜炎(TBM)合并脑积水患儿脑脊液和血液中的神经损伤标志物(S100B、NSE、GFAP)及炎症标志物,并与脂肪酸终丝和肺结核对照组比较。结果显示脑脊液标志物升高持续3周,S100B和NSE初始及最高浓度与不良结局相关,标志物上升趋势提示持续脑损伤,而炎症标志物随治疗下降。
要点
- 脑脊液S100B和NSE初始及第1周最高浓度与TBM患儿不良结局相关。
- 神经标志物持续上升提示脑损伤进展,即使炎症标志物下降。
- 脑梗死与最高整体神经标志物浓度及上升趋势相关。
核心结论
- 脑脊液神经标志物是评估TBM损伤严重程度和预测死亡的有前景的生物标志物。
研究设计与样本
- 前瞻性观察性研究,纳入44例TBM合并脑积水患儿(中位年龄3.3岁),11例脂肪酸终丝对照和9例肺结核对照。
主要发现
- 7例(16%)死亡,16例(36%)遗留残疾。
- 脑脊液神经标志物和炎症标志物入院时及至3周内升高,血清中未升高。
- S100B和NSE初始及第1周最高浓度与不良结局相关;S100B、NSE、GFAP整体最高浓度及随时间上升趋势亦与不良结局相关。
- 死亡患儿神经标志物组合浓度随时间上升,而炎症标志物下降。
- 脑梗死与最高整体神经标志物浓度及随时间上升趋势相关;结核瘤与IL-12p40、IP-10、MCP-1升高相关;梗死与TNF-α、MIP-1α、IL-6、IL-8升高相关。
关键数值与推荐
- 脑脊液S100B和NSE初始及第1周最高浓度与不良结局相关。
- S100B、NSE、GFAP整体最高浓度及上升趋势与不良结局相关。
临床怎么用
- 脑脊液神经标志物可用于评估TBM患儿损伤严重程度和预测死亡。
- 神经标志物上升趋势提示持续脑损伤,需关注即使炎症标志物下降。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tuberculous meningitis (TBM) leads to death or disability in half the affected individuals. Tools to assess severity and predict outcome are lacking. Neurospecific biomarkers could serve as markers of the severity and evolution of brain injury, but have not been widely explored in TBM. We examined biomarkers of neurological injury (neuromarkers) and inflammation in pediatric TBM and their association with outcome. METHODS: Blood and cerebrospinal fluid (CSF) of children with TBM and hydrocephalus taken on admission and over 3 weeks were analyzed for the neuromarkers S100B, neuron-specific enolase (NSE), and glial fibrillary acidic protein (GFAP), in addition to multiple inflammatory markers. Results were compared with 2 control groups: patients with (1) a fatty filum (abnormal filum terminale of the spinal cord); and (2) pulmonary tuberculosis (PTB). Imaging was conducted on admission and at 3 weeks. Outcome was assessed at 6 months. RESULTS: Data were collected from 44 patients with TBM (cases; median age, 3.3 [min-max 0.3-13.1] years), 11 fatty filum controls (median age, 2.8 [min-max 0.8-8] years) and 9 PTB controls (median age, 3.7 [min-max 1.3-11.8] years). Seven cases (16%) died and 16 (36%) had disabilities. Neuromarkers and inflammatory markers were elevated in CSF on admission and for up to 3 weeks, but not in serum. Initial and highest concentrations in week 1 of S100B and NSE were associated with poor outcome, as were highest concentration overall and an increasing profile over time in S100B, NSE, and GFAP. Combined neuromarker concentrations increased over time in patients who died, whereas inflammatory markers decreased. Cerebral infarcts were associated with highest overall neuromarker concentrations and an increasing profile over time. Tuberculomas were associated with elevated interleukin (IL) 12p40, interferon-inducible protein 10, and monocyte chemoattractant protein 1 concentrations, whereas infarcts were associated with elevated tumor necrosis factor α, macrophage inflammatory protein 1α, IL-6, and IL-8. CONCLUSIONS: CSF neuromarkers are promising biomarkers of injury severity and are predictive of mortality. An increasing trend suggested ongoing brain injury, even though markers of inflammation declined with treatment. These findings could offer novel insight into the pathophysiology of TBM.
引用
- Rohlwink UK, Mauff K, Wilkinson KA, et al. Biomarkers of Cerebral Injury and Inflammation in Pediatric Tuberculous Meningitis. Clin Infect Dis. 2017. PMID: 28605426. doi:10.1093/cid/cix540
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。